KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update
KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the most volatile biotech penny stocks on the market in late 2025. After a failed eye‑disease trial, a loan default and a near‑miss with foreclosure, the company is now trying